- Home
- Publications
- Publication Search
- Publication Details
Title
Renal cell carcinoma
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 17009
Publisher
Springer Nature
Online
2017-03-09
DOI
10.1038/nrdp.2017.9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
- (2017) James J. Hsieh et al. EUROPEAN UROLOGY
- Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems
- (2017) Daniela Rodrigues et al. Translational Research
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) B. Escudier et al. ANNALS OF ONCOLOGY
- Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma
- (2016) Martin H Voss et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
- (2016) A. Ari Hakimi et al. CANCER CELL
- Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
- (2016) D. J. Kwiatkowski et al. CLINICAL CANCER RESEARCH
- Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs
- (2016) Chung-Han Lee et al. Clinical Genitourinary Cancer
- Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database
- (2016) I. Wolff et al. EJSO
- The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016
- (2016) Axel Bex et al. EUROPEAN UROLOGY
- Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial
- (2016) Nizar M. Tannir et al. EUROPEAN UROLOGY
- Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations
- (2016) Gabriel G. Malouf et al. EUROPEAN UROLOGY
- Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy
- (2016) Lorenzo Marconi et al. EUROPEAN UROLOGY
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin
- (2016) Jianing Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome
- (2016) Sarah M. Nielsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
- (2016) Laurence Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma
- (2016) Thomas Powles et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study
- (2016) Nawar Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non–Clear Cell Renal Cell Carcinoma
- (2016) Martin H. Voss et al. JOURNAL OF CLINICAL ONCOLOGY
- MP71-03 DEVELOPMENT OF A CLEAR CELL RENAL CELL CARCINOMA XENOGRAFT MODEL: A CASE FOR THE USE OF BIOPSY TISSUE OVER SURGICAL TISSUE
- (2016) Yiyu Dong et al. JOURNAL OF UROLOGY
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial
- (2016) David Cella et al. LANCET ONCOLOGY
- Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
- (2016) Andrew J Armstrong et al. LANCET ONCOLOGY
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
- (2016) Hyejin Cho et al. NATURE
- Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
- (2016) Alain Ravaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
- (2016) Maria I. Carlo et al. ONCOLOGIST
- Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma
- (2016) Mark Bi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma
- (2016) Limin Zhang et al. BioScience Trends
- Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
- (2016) Ying-Bei Chen et al. Nature Communications
- Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41
- (2016) Pierre Bigot et al. Nature Communications
- Introduction to small renal tumours and prognostic indicators
- (2016) Alessandro Crestani et al. International Journal of Surgery
- Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
- (2016) Fengju Chen et al. Cell Reports
- Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components
- (2016) Brandon J. Manley et al. Translational Cancer Research
- Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
- (2016) Stefan Winter et al. Scientific Reports
- Hereditary Renal Cell Carcinoma Syndromes
- (2015) Adebowale J. Adeniran et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients
- (2015) Frede Donskov et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis
- (2015) H. I. Wettersten et al. CANCER RESEARCH
- PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises
- (2015) F. Massari et al. CANCER TREATMENT REVIEWS
- Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
- (2015) N. A. Giraldo et al. CLINICAL CANCER RESEARCH
- Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
- (2015) B. Beuselinck et al. CLINICAL CANCER RESEARCH
- A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer
- (2015) Laurence Albiges et al. EUROPEAN UROLOGY
- Systemic Therapy for Non–clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis
- (2015) Francisco E. Vera-Badillo et al. EUROPEAN UROLOGY
- Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
- (2015) Phillip M. Pierorazio et al. EUROPEAN UROLOGY
- Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
- (2015) Brian Shuch et al. EUROPEAN UROLOGY
- International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
- (2015) Ariana Znaor et al. EUROPEAN UROLOGY
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update
- (2015) Borje Ljungberg et al. EUROPEAN UROLOGY
- A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy
- (2015) Tobias Klatte et al. EUROPEAN UROLOGY
- Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach
- (2015) Suzanne B. Stewart-Merrill et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
- (2015) Robert J Motzer et al. LANCET ONCOLOGY
- A river model to map convergent cancer evolution and guide therapy in RCC
- (2015) Elizabeth Y. Wei et al. Nature Reviews Urology
- Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
- (2015) L Zhou et al. ONCOGENE
- SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
- (2015) N Kanu et al. ONCOGENE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma
- (2015) Soo Jeong Nam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Immune signature of tumor infiltrating immune cells in renal cancer
- (2015) Katharina Geissler et al. OncoImmunology
- Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma
- (2015) Jeremiah J. Morrissey et al. JAMA Oncology
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
- (2015) Asim Amin et al. Journal for ImmunoTherapy of Cancer
- Metastatic Non-Clear Cell Renal Cell Carcinoma: An Evidence Based Review of Current Treatment Strategies
- (2015) Alexander Sankin et al. Frontiers in Oncology
- The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
- (2014) Caleb F. Davis et al. CANCER CELL
- Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
- (2014) M. H. Voss et al. CLINICAL CANCER RESEARCH
- ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
- (2014) Samira A. Brooks et al. EUROPEAN UROLOGY
- Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
- (2014) Sakshi Gulati et al. EUROPEAN UROLOGY
- Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma
- (2014) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib
- (2014) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robotic versus Open Partial Nephrectomy: A Systematic Review and Meta-Analysis
- (2014) Zhenjie Wu et al. PLoS One
- Bap1is essential for kidney function and cooperates withVhlin renal tumorigenesis
- (2014) Shan-Shan Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff
- (2014) Géraldine Pignot et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity
- (2014) B. C. Grabiner et al. Cancer Discovery
- The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
- (2014) Alexander Sankin et al. Cancer Medicine
- Hereditary Kidney Cancer Syndromes
- (2013) Naomi B. Haas et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
- (2013) John R. Srigley et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comparison of peri-operative outcomes of robot-assisted vs laparoscopic partial nephrectomy: a meta-analysis
- (2013) Xiaohua Zhang et al. BJU INTERNATIONAL
- A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy
- (2013) Vincenzo Ficarra et al. BJU INTERNATIONAL
- Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria
- (2013) Nils Kroeger et al. CANCER
- A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma
- (2013) Tomohiro Funakoshi et al. CANCER TREATMENT REVIEWS
- Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
- (2013) R. Remark et al. CLINICAL CANCER RESEARCH
- Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
- (2013) A. A. Hakimi et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
- (2013) A.M. Molina et al. EUROPEAN JOURNAL OF CANCER
- Renal Function After Nephron-sparing Surgery Versus Radical Nephrectomy: Results from EORTC Randomized Trial 30904
- (2013) Emil Scosyrev et al. EUROPEAN UROLOGY
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management
- (2013) Brian Shuch et al. JOURNAL OF CLINICAL ONCOLOGY
- An Epidemiologic and Genomic Investigation Into the Obesity Paradox in Renal Cell Carcinoma
- (2013) A. Ari Hakimi et al. JNCI-Journal of the National Cancer Institute
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
- (2013) Payal Kapur et al. LANCET ONCOLOGY
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
- (2013) Daniel YC Heng et al. LANCET ONCOLOGY
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- A clear picture of renal cell carcinoma
- (2013) A Ari Hakimi et al. NATURE GENETICS
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations
- (2013) Christoph A. Karlo et al. RADIOLOGY
- Non-Clear Cell Renal Cancer: Disease-Based Management and Opportunities for Targeted Therapeutic Approaches
- (2013) W. Marston Linehan et al. SEMINARS IN ONCOLOGY
- Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future
- (2013) Tobias Janowitz et al. SEMINARS IN ONCOLOGY
- A common variant at 8q24.21 is associated with renal cell cancer
- (2013) Julius Gudmundsson et al. Nature Communications
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
- Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies
- (2012) Regina El Dib et al. BJU INTERNATIONAL
- Growth kinetics and active surveillance for small renal masses
- (2012) Brian R. Lane et al. CURRENT OPINION IN UROLOGY
- Systematic Review of Perioperative and Quality-of-life Outcomes Following Surgical Management of Localised Renal Cancer
- (2012) Steven MacLennan et al. EUROPEAN UROLOGY
- Robotic Versus Laparoscopic Partial Nephrectomy: A Systematic Review and Meta-Analysis
- (2012) Omar M. Aboumarzouk et al. EUROPEAN UROLOGY
- A Review of Integrated Staging Systems for Renal Cell Carcinoma
- (2012) Malek Meskawi et al. EUROPEAN UROLOGY
- Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer
- (2012) Steven MacLennan et al. EUROPEAN UROLOGY
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
- (2012) A. Ari Hakimi et al. EUROPEAN UROLOGY
- Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer
- (2012) Marc Henrion et al. HUMAN MOLECULAR GENETICS
- Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin
- (2012) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
- (2012) Hai T Tran et al. LANCET ONCOLOGY
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
- (2012) Johannes Schödel et al. NATURE GENETICS
- Evolution of the cancer genome
- (2012) Lucy R. Yates et al. NATURE REVIEWS GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- An overview of renal cell cancer: Pathology and genetics
- (2012) Holger Moch SEMINARS IN CANCER BIOLOGY
- Differential Diagnosis of Renal Tumors With Papillary Architecture
- (2011) Satish K. Tickoo et al. ADVANCES IN ANATOMIC PATHOLOGY
- Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
- (2011) Ana M. Molina et al. CANCER
- Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
- (2011) Eric Tartour et al. CANCER AND METASTASIS REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Current Pathology Keys of Renal Cell Carcinoma
- (2011) Ferran Algaba et al. EUROPEAN UROLOGY
- Positive Surgical Margins After Nephron-Sparing Surgery
- (2011) Martin Marszalek et al. EUROPEAN UROLOGY
- A Non–Cancer-Related Survival Benefit Is Associated With Partial Nephrectomy
- (2011) Maxine Sun et al. EUROPEAN UROLOGY
- A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23
- (2011) Xifeng Wu et al. HUMAN MOLECULAR GENETICS
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Patient-Reported Outcomes in a Phase III Study of Everolimus Versus Placebo in Patients with Metastatic Carcinoma of the Kidney That Has Progressed on Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
- (2011) J. L. Beaumont et al. ONCOLOGIST
- Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
- (2010) S Yang et al. BRITISH JOURNAL OF CANCER
- Family history of cancer and renal cell cancer risk in Caucasians and African Americans
- (2010) S Karami et al. BRITISH JOURNAL OF CANCER
- Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Partial Nephrectomy Is Associated with Improved Overall Survival Compared to Radical Nephrectomy in Patients with Unanticipated Benign Renal Tumours
- (2010) Christopher J. Weight et al. EUROPEAN UROLOGY
- Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis
- (2010) Maxine Sun et al. EUROPEAN UROLOGY
- A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
- (2010) Hendrik Van Poppel et al. EUROPEAN UROLOGY
- Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
- (2010) Mark P Purdue et al. NATURE GENETICS
- The genetic basis of kidney cancer: a metabolic disease
- (2010) W. Marston Linehan et al. Nature Reviews Urology
- Epidemiology and risk factors for kidney cancer
- (2010) Wong-Ho Chow et al. Nature Reviews Urology
- Differential diagnosis of renal tumours with clear cell histology
- (2010) Victor E. Reuter et al. PATHOLOGY
- Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomes
- (2009) David Cella CANCER TREATMENT REVIEWS
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Guideline for Management of the Clinical T1 Renal Mass
- (2009) Steven C. Campbell et al. JOURNAL OF UROLOGY
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
- (2009) Janice P. Dutcher et al. MEDICAL ONCOLOGY
- Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study
- (2008) Ryan P Theis et al. BMC CANCER
- The VHL tumor suppressor and HIF: insights from genetic studies in mice
- (2008) P P Kapitsinou et al. CELL DEATH AND DIFFERENTIATION
- Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881
- (2008) Jan H.M. Blom et al. EUROPEAN UROLOGY
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Fat, Protein, and Meat Consumption and Renal Cell Cancer Risk: A Pooled Analysis of 13 Prospective Studies
- (2008) Jung Eun Lee et al. JNCI-Journal of the National Cancer Institute
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Statins Might Reduce Risk of Renal Cell Carcinoma in Humans: Case-Control Study of 500,000 Veterans
- (2008) Vikas Khurana et al. UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started